Cointime

Sears Capital Management

investment firm

About

Sears Capital Management is a venture investment and portfolio management firm focused on the life sciences industry.

Highlights

Investments
8
Lead Investments
1
Exits
3
Employee Profiles
2

Details

Founded date
Jan 1, 1994
Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
8
1
Sears Capital Management has made 8 investments. Their most recent investment was on Jan 6, 2017, when SiteOne Therapeutics raised $15M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 6, 2017 SiteOne Therapeutics
Series B $15M Biotechnology —
Jul 15, 2015 SiteOne Therapeutics
Series Unknown $1.27M Biotechnology —
Sep 24, 2014 SiteOne Therapeutics
Series A $1.50M Biotechnology Yes
Jan 29, 2013 CharlestonPharma,LLC
Seed $1.60M Biotechnology —
Aug 4, 2008 InteKrin
Series C $18.50M Biotechnology —
Show More

Employee Profiles

Number of Employee Profiles
2
Sears Capital Management has 2 current employee profiles, including Executive Lowell Sears
Lowell Sears
Executive
Lowell Sears
Board member

Exits

Sears Capital Management has had 3 exits. Sears Capital Management most notable exits include Anthera Pharmaceuticals ,   InteKrin

Date Company Name Exit Type Industry
Jun 28, 2018 Anthera Pharmaceuticals IPO Biotechnology Detail
Feb 12, 2014 InteKrin M&A Biotechnology Detail
Apr 19, 2005 Peninsula Pharmaceuticals M&A Biopharma Detail
Cointime
İçerikler
Şirket.